as 11-04-2025 3:47pm EST
American Shared Hospital Services provides stereotactic radiosurgery equipment, Advanced radiation therapy, and related equipment. It currently provides Gamma Knife units to medical centers and stand-alone facilities. The company, along with its subsidiaries, operates through the following operations: Gamma Knife, Advanced Radiation Therapy Equipment and Services, and Proton Beam Radiation Therapy Operations. It generates most of its revenue from the domestic market.
| Founded: | 1980 | Country: | United States |
| Employees: | N/A | City: | SAN FRANCISCO |
| Market Cap: | 14.7M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 26.1K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.37 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.01 - $3.59 | Next Earning Date: | 11-11-2025 |
| Revenue: | $29,251,000 | Revenue Growth: | 26.61% |
| Revenue Growth (this year): | 5.06% | Revenue Growth (next year): | N/A |
AMS Breaking Stock News: Dive into AMS Ticker-Specific Updates for Smart Investing
Simply Wall St.
a month ago
PR Newswire
2 months ago
GuruFocus.com
6 months ago
Thomson Reuters StreetEvents
6 months ago
Zacks Small Cap Research
6 months ago
GlobeNewswire
6 months ago
GlobeNewswire
6 months ago
GlobeNewswire
7 months ago
The information presented on this page, "AMS American Shared Hospital Services - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.